Yubo International Biotech (YBGJ) versus The Competition Financial Contrast

Earnings & Valuation

This table compares Yubo International Biotech and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Yubo International Biotech	$610,000.00	-$1.20 million	-8.62
Yubo International Biotech Competitors	$1.01 billion	$83.13 million	10.29

Yubo International Biotech’s rivals have higher revenue and earnings than Yubo International Biotech. Yubo International Biotech is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

Yubo International Biotech has a beta of 3.09, suggesting that its share price is 209% more volatile than the S&P 500. Comparatively, Yubo International Biotech’s rivals have a beta of 0.92, suggesting that their average share price is 8% less volatile than the S&P 500.

Institutional & Insider Ownership

44.3% of shares of all “Electromedical equipment” companies are held by institutional investors. 56.5% of Yubo International Biotech shares are held by company insiders. Comparatively, 15.3% of shares of all “Electromedical equipment” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares Yubo International Biotech and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Yubo International Biotech	-274.96%	N/A	-121.41%
Yubo International Biotech Competitors	-299.60%	-764.44%	-27.12%

Yubo International Biotech Company Profile

Yubo International Biotech Limited, through its subsidiaries, focuses on the research and development, and application of endometrial stem cells. It offers healthcare products for respiratory system, skincare products, hair care products, healthy beverages, and male and female personal care products; and stem cell related services, including cell testing and health management consulting services under the VIVCELL brand. The company is headquartered in Beijing, China.